Investor Atlas

2080 Ventures · Investor research

74 investors focused on Biotech targeting Switzerland

Compare 74 investors focused on Biotech targeting Switzerland. Review the selection, investor types and reported focus with 2080 Ventures.

74matching investors
3individual investors
71organizations

What this selection covers

This guide contains 74 distinct directory identities matching target markets: Switzerland; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Switzerland” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (60), Corporate Venture Capital (5), Private Equity (5), Accelerator (4).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for Switzerland, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 74 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
5AM Ventures
Venture CapitalView profile ↗
ABAB (Atlantic Business Angels Booster)
Angel NetworkView profile ↗
Abingworth
Venture CapitalView profile ↗
Aisling Capital
Private EquityView profile ↗
Amino Collective
Venture CapitalView profile ↗
Ananda Impact Ventures
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Apollo Health Ventures
Venture CapitalView profile ↗
Arcanum Ventures
Venture CapitalView profile ↗
ArcTern Ventures
Venture CapitalView profile ↗
Ardian
Private EquityView profile ↗
Arkin Holdings
Private EquityView profile ↗
Astanor Ventures
Venture CapitalView profile ↗
Atlas Venture
Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Balderton Capital
Venture CapitalView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Boost VC
Venture Capital, AcceleratorView profile ↗
Breakthrough Energy Ventures
Venture CapitalView profile ↗
Cherubic Ventures
Venture CapitalView profile ↗
EQT Ventures
Venture Capital, Family OfficeView profile ↗
EXPERT DOJO
Venture Capital, AcceleratorView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
FLORA Ventures
Venture CapitalView profile ↗
Forbion Capital Partners
Venture CapitalView profile ↗
Forty51 Ventures
Venture CapitalView profile ↗
Fountain Healthcare Partners
Venture CapitalView profile ↗
General Atlantic
Venture CapitalView profile ↗
General Inception
Startup StudioView profile ↗
Gilde Healthcare
Venture CapitalView profile ↗
Ginkgo Equity
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
HBM Partners
Private EquityView profile ↗
Henry Stebbins
Angel InvestorView profile ↗
HomeLab Powered By LabFellows
AcceleratorView profile ↗
Humboldt Fund
Venture CapitalView profile ↗
Index Ventures
Venture CapitalView profile ↗
IndieBio
Venture CapitalView profile ↗
Innoviva
Venture CapitalView profile ↗
Medin VC
Venture CapitalView profile ↗
Michael Wieser
Angel InvestorView profile ↗
Mindshift Ventures
Venture CapitalView profile ↗
Mission BioCapital
Venture CapitalView profile ↗
Mountain Labs
Venture CapitalView profile ↗
Nelli Morgulchik
Angel InvestorView profile ↗
Neotribe Ventures
Venture CapitalView profile ↗
Notion Capital
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
OrbiMed
Private EquityView profile ↗
Panakes Partners
Venture CapitalView profile ↗
Pear VC
Venture CapitalView profile ↗
Pfizer Venture Investments
Venture Capital, Corporate Venture CapitalView profile ↗
Pioneer Fund
Venture Capital, SyndicateView profile ↗
Polaris Partners
Venture CapitalView profile ↗
Privilège Ventures
Venture CapitalView profile ↗
Pureos Bioventures
Venture CapitalView profile ↗
Right Side Capital Management
Venture CapitalView profile ↗
SEE UP Accelerator
AcceleratorView profile ↗
Signet Healthcare Partners
Venture CapitalView profile ↗
Sofinnova Partners
Venture CapitalView profile ↗
Supermoon Capital
Venture CapitalView profile ↗
SV Health Investors
Venture CapitalView profile ↗
Target Global
Venture CapitalView profile ↗
True Ventures
Venture CapitalView profile ↗
TVM Capital
Venture CapitalView profile ↗
Venga Ventures
Venture CapitalView profile ↗
Venrock
Venture CapitalView profile ↗
Versant Ventures
Venture CapitalView profile ↗
Walden Catalyst
Venture CapitalView profile ↗
Wellcome Trust
Public FundView profile ↗
Young Ventures
Venture CapitalView profile ↗
ZAKA VC
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.